SCHEMBL7827008

SCHEMBL7827008

COC(=O)c1cccc(-c2cccc(Cl)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLAU P00749 2/20 0.59
▸ CA12 O43570 1/20 0.57
▸ CA1 P00915 1/20 0.57
▸ CA2 P00918 1/20 0.57
▸ CA9 Q16790 1/20 0.57
▸ SLC6A3 Q01959 4/20 0.56
▸ ERN1 O75460 3/20 0.56
▸ ADRB2 P07550 1/20 0.55
▸ ADRB1 P08588 1/20 0.55
▸ ADRB3 P13945 1/20 0.55
▸ SLC6A2 P23975 1/20 0.55
▸ NPC1 O15118 2/20 0.54
▸ MAPT P10636 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ GABRG2 P18507 1/20 0.54
▸ GABRB3 P28472 1/20 0.54
▸ GABRA5 P31644 1/20 0.54
▸ GABRA3 P34903 1/20 0.54
▸ HSD17B3 P37058 1/20 0.53
▸ RXRA P19793 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3511154 0.92 SLC6A3 (0.55) PLAUCA12CA1CA2CA9
SCHEMBL8444016 0.92 RXRA (0.65) PLAUCA12CA1CA2CA9
SCHEMBL642345 0.89 RAB9A (0.59) NPC1MAPTRAB9AATMTSHR
SCHEMBL29406761 0.89 RAB9A (0.59) NPC1MAPTRAB9AATMTSHR
SCHEMBL67941 0.89 CA12 (0.68) PLAUCA12CA1CA2CA9
SCHEMBL27715902 0.87 CA12 (0.71) PLAUCA12CA1CA2CA9
SCHEMBL1938488 0.87 KDM4C (0.58) PLAUCA12CA1CA2CA9
SCHEMBL4592371 0.85 CYP11B1 (0.58) PLAUSLC6A3SLC6A2GABRG2GABRB3
Methylene Chloride SCHEMBL29256423 0.84 LOXL2 (0.56) NPC1MAPTRAB9AATMTSHR
SCHEMBL1681182 0.84 RAB9A (0.55) NPC1MAPTRAB9AATMTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1080257-C Guanidine derivatives as inhibitors of Na+/H+ exchange in cells FUJISAWA PHARMACEUTICAL CO (JP) 2002-03-06 — — CN disclosed
EP-0699185-B1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO (JP) 2001-09-05 — — EP disclosed
US-5824691-A CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-10-20 — — US disclosed
CN-1123545-A Guanidine derivatives as inhibitors of Na+/H+ exchange in cells FUJISAWA PHARMACEUTICAL CO (JP) 1996-05-29 — — CN disclosed
EP-0699185-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-03-06 — — EP disclosed
WO-1994026709-A1 GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-24 — — WO disclosed
Send feedback